Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study. J Clin Oncol. 1989 Jun; 7(6):761-8.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow
Carcinoma
Carcinoma, Squamous Cell
Combined Modality Therapy
Drug Evaluation
Female
Fluorouracil
Follow-Up Studies
Head and Neck Neoplasms
Humans
Hydroxyurea
Male
Middle Aged
Prognosis
Stomatitis

authors with profiles

Richard Schilsky
Azhar M. Awan
Ralph R. Weichselbaum